Literature DB >> 9507391

P67L: a cystic fibrosis allele with mild effects found at high frequency in the Scottish population.

A Gilfillan1, J P Warner, J M Kirk, T Marshall, A Greening, L P Ho, T Hargreave, B Stack, D McIntyre, R Davidson, J C Dean, W Middleton, D J Brock.   

Abstract

Only three mutant cystic fibrosis (CF) alleles have to date been established as conferring a dominant mild effect on affected subjects who are compound heterozygotes. We now add a fourth, P67L, which occurs on about 1.4% of Scottish CF chromosomes. Among 13 patients (12 unrelated) with this allele, the average age at diagnosis was 22.5 +/- 11.3 years. None of the cases had consistently raised sweat chloride concentrations, the average value being 57 +/- 9 mmol/l; 77% of the patients were pancreatic sufficient. When compared to three other established mild CF alleles, R117H, A455E, and 3849 + 10kb C-T, a compound heterozygote for P67L has minimal disease and clinical suspicions are unlikely to be confirmed other than by DNA typing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507391      PMCID: PMC1051215          DOI: 10.1136/jmg.35.2.122

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  A new missense mutation (R1283M) in exon 20 of the cystic fibrosis transmembrane conductance regulator gene.

Authors:  J P Cheadle; A L Meredith; L N al-Jader
Journal:  Hum Mol Genet       Date:  1992-05       Impact factor: 6.150

2.  Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation.

Authors:  C T Jones; I McIntosh; M Keston; A Ferguson; D J Brock
Journal:  Hum Mol Genet       Date:  1992-04       Impact factor: 6.150

3.  A 22-bp deletion in the coding region of the cystic fibrosis gene.

Authors:  M Dean; M B White; B Gerrard; A Milunsky; J Amos
Journal:  Genomics       Date:  1992-05       Impact factor: 5.736

4.  Fluorescent multiplex microsatellites used to define haplotypes associated with 75 CFTR mutations from the UK on 437 CF chromosomes.

Authors:  D Hughes; A Wallace; J Taylor; M Tassabehji; R McMahon; A Hill; N Nevin; C Graham
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

5.  Variation of sweat sodium and chloride with age in cystic fibrosis and normal populations: further investigations in equivocal cases.

Authors:  J M Kirk; M Keston; I McIntosh; S al Essa
Journal:  Ann Clin Biochem       Date:  1992-03       Impact factor: 2.057

6.  Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy.

Authors:  M Devoto; P Ronchetto; P Fanen; J J Orriols; G Romeo; M Goossens; M Ferrari; C Magnani; M Seia; L Cremonesi
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

7.  Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis.

Authors:  A Anguiano; R D Oates; J A Amos; M Dean; B Gerrard; C Stewart; T A Maher; M B White; A Milunsky
Journal:  JAMA       Date:  1992-04-01       Impact factor: 56.272

8.  Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  T V Strong; L S Smit; S Nasr; D L Wood; J L Cole; M C Iannuzzi; R C Stern; F S Collins
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

9.  Detection of over 98% cystic fibrosis mutations in a Celtic population.

Authors:  C Férec; M P Audrezet; B Mercier; H Guillermit; P Moullier; I Quere; C Verlingue
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

10.  Cystic-fibrosis screening in the newborn.

Authors:  J R Crossley; C C Berryman; R B Elliott
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

View more
  3 in total

1.  Genotype-phenotype correlation for pulmonary function in cystic fibrosis.

Authors:  J de Gracia; F Mata; A Alvarez; T Casals; S Gatner; M Vendrell; D de la Rosa; L Guarner; E Hermosilla
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

2.  Ubiquitination of disease-causing CFTR variants in a microsome-based assay.

Authors:  Samuel K Estabrooks; Jeffrey L Brodsky
Journal:  Anal Biochem       Date:  2020-07-01       Impact factor: 3.365

3.  Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases.

Authors:  Carleen M Sabusap; Wei Wang; Carmel M McNicholas; W Joon Chung; Lianwu Fu; Hui Wen; Marina Mazur; Kevin L Kirk; James F Collawn; Jeong S Hong; Eric J Sorscher
Journal:  JCI Insight       Date:  2016-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.